Discontinuous to Continuous Therapy with 0.2 μg/day Fluocinolone Acetonide implant (FAc) Leads to Reduction in Treatment Frequency for Diabetic Macular Edema (DME)

被引：0
|
作者：
Adams, Olufemi E. [1 ]
Schechet, Sidney [1 ]
Hariprasad, Seenu [1 ]
机构：
[1] Univ Chicago, Ophthalmol, Chicago, IL 60637 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2614
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of Refractory Diabetic Macular Edema with Intravitreal Injection of a Fluocinolone Acetonide Implant
    Rubino, Shaina M.
    Komanski, Chris Bligh
    John, Vishak J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Clinical Outcomes in Treatment of Diabetic Macular Edema with Fluocinolone Acetonide Intravitreal Implant
    West, Matthew
    Kim, Samuel
    Khanifar, A. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [23] Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
    Mushtaq, Bushra
    Bhatnagar, Ajay
    Palmer, Helen
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 2935 - 2943
  • [24] Real-life visual and anatomical outcomes with fluocinolone acetonide (FAc) and cumulative cost of treatment in the treatment of chronic diabetic macular edema (DME)
    Goncalves, Rita
    Coelho, Pedro
    Teixeira, Carla
    Carvalho, Rui
    Vieira, Bruna
    Maio, Tiago
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [25] Changes in the cup-to-disc ratio in patients with diabetic macular edema (DME) treated with fluocinolone acetonide (FAc) implants
    Parrish, Richard K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [26] EFFICACY RESULTS OF 0.2.G/DAY FLUOCINOLONE ACETONIDE IMPLANT (FAC) IN DMO VITRECTOMISED PATIENTS
    Erginay, A.
    Habib, M.
    Goldsmith, C.
    Schmit-Eilenberger, V.
    Massin, P.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E109 - E110
  • [27] ICE-UK - The evaluation of the fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular edema (DME) in NHS clinical practice
    Collins, Daniela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [28] Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant
    Ciulla, Thomas A.
    Harris, Alon
    McIntyre, Nathaniel
    Jonescu-Cuypers, Christian
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (07) : 953 - 959
  • [29] The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus
    Kolomeyer, Anton M.
    Eichenbaum, David A.
    Kiernan, Daniel F.
    Suner, Ivan J.
    Hariprasad, Seenu M.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2023, 54 (03): : 166 - +
  • [30] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2018, 7 : 293 - 305
12345